Home Cart Sign in  
Chemical Structure| 112228-65-6 Chemical Structure| 112228-65-6

Structure of B220
CAS No.: 112228-65-6

Chemical Structure| 112228-65-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

B220 is an antiviral agent which can inhibit the growth of HSV-1, HSV-2 and human cytomegalovirus (CMV).

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of B220

CAS No. :112228-65-6
Formula : C20H22N4
M.W : 318.42
SMILES Code : CC1=C(C)C=C2N=C3C(N(CCN(C)C)C4=C3C=CC=C4)=NC2=C1
MDL No. :MFCD00835300

Safety of B220

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00915343 Adrenal Insufficiency Phase 2 Phase 3 Completed - -
NCT00690638 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01174225 Contraception Phase 4 Active, not recruiting December 2020 Canada, British Columbia ... More >> Kelowna Womens' Clinic Kelowna, British Columbia, Canada Less <<
NCT02509247 Sleep Apnea Not Applicable Completed - Finland ... More >> Turku University Hospital Turku, Finland, 20521 Less <<
NCT00363012 Breast Cancer Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109-1024 Tumor Vaccine Group at the University of Washington Seattle, Washington, United States, 98109 Less <<
NCT00915343 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.14mL

0.63mL

0.31mL

15.70mL

3.14mL

1.57mL

31.41mL

6.28mL

3.14mL

 

Historical Records

Categories